+1-888-308-5802     
News Contact Us

U.K. PM signals return to normalcy with easing of COVID-19 restrictions

Author : Pankaj Singh | Published Date : 2021-07-07 

British Prime Minister Boris Johnson has announced plans to end the economic and social restrictions associated with the COVID-19 pandemic in the United Kingdom in the next two weeks.

The decision has been taken with the aim of testing whether rapid vaccine rollouts have offered sufficient protection from the most recent and highly contagious Delta variant.

Prime Minister Johnson stated that the government plans to remove the restrictive measures on July 19, with a final pronouncement to be made next week. He also said that the step would end all formal regulations on social contact, requirements to work from home, and mandates on using face masks.

There will be no limits on capacity in the hospitality sector and nightclubs will be allowed to reopen with all social distancing guidelines being scrapped.

Johnson was also quoted saying that the country will stop imposing legal restrictions and allow the people to make informed decisions to cope with the virus.

Meanwhile, the Prime Minister is betting that the vaccination program, which has brought down the rates of hospital admissions linked with infections, will prevent the health service industry from being overburdened by another new wave of infections.

It is also worth noting that Britain has recorded the world’s seventh-highest death toll from COVID-19, and Johnson has been heavily criticized for not being prompt enough to implement the lockdowns.

However, vaccine rollouts have been highly efficient in the country, with 86% of adults already being administered their first dose, and 64% received two doses as of this week.

These figures provided by Public Health England have revealed that vaccines are considered effective in preventing the Delta variant from causing hospitalizations or severe illness.

In the meantime, over five million Britons who have taken the Indian-made AstraZeneca jab might face restrictions on travel to European countries, as the vaccine has not been approved by the European Medicines Agency (EMA), cited sources with knowledge of the matter.

Source Links –

https://www.nbcnews.com/news/world/u-k-pm-johnson-outlines-end-england-s-virus-restrictions-n1273088

About Author

Pankaj Singh

Pankaj Singh

Endowed with a post graduate degree in management and finance, Pankaj Singh has been a part of the online content domain for quite a while. Having worked previously as a U.K. insurance underwriter for two years, he now writes articles for fractovia.org and other online portals. He can be contacted at- [email protected] | https://twitter.com/PankajSingh2605

Related News

Kennon Robotics bags USD 200 million to expand into unexplored markets

Published Date: 2021-09-17         Author: Pankaj Singh

Shanghai-based service robotics company Keenon Robotics Co. Ltd. has reportedly raised USD 200 million in a Series D funding round which was led by Softbank Vision Fund 2. This is considered to be the largest funding to date in the service robot business space. The funding round also saw particip... Read More

U.S. regulator seeks data from 12 automakers for Tesla Autopilot probe

Published Date: 2021-09-16         Author: Pankaj Singh

The National Highway Traffic Safety Administration (NHTSA), recently requested 12 major automakers for aid as a part of the investigation into crashes involving Tesla cars into other vehicles while using its advanced driver assistance system (ADAS), the Tesla Autopilot. It is to be noted that Tesla... Read More

Battery Ventures acquires Goodfellow to expand its product portfolio

Published Date: 2021-09-15         Author: Pankaj Singh

Boston-based venture capital firm Battery Ventures recently revealed to have acquired Goodfellow Cambridge Ltd., a specialty provider of superior quality materials for R&D, prototyping, and specialized manufacturing. Goodfellow, based in Cambridgeshire, U.K., also has subsidiaries in France, ... Read More

© 2021 Fractovia. All Rights Reserved